Lynda Merrill

Fluoresentric has appointed Lynda Merrill as CEO, replacing previous CEO William Olson. Merrill is currently a board member of Fluoresentric subsidiary XCR Diagnostics, a position she will continue to hold. She has also held senior management positions at Qiagen, Boehringer Mannheim, Gen-Probe, and Immunodiagnostic Systems.


Bob Barrett

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.